FDA Alert
FDA Alert
04/18/2024

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approved givinostat, a nonsteroidal oral medication, for treating patients 6 years of age or older with Duchenne muscular dystrophy.
04/18/2024
FDA ALERT
FDA ALERT
04/18/2023
Jessica Ganga
The FDA has approved a treatment for Friedreich ataxia after the results of randomized, placebo-controlled study indicate a strong effectiveness in treatment.
04/18/2023
Conference Coverage
Conference Coverage
11/18/2022
Jennifer Hui, MD, discusses the different movement disorders and elaborates on idiopathic Parkinson disease, discussing its symptoms and treatment, in her session at the Practical Updates in Primary Care...
11/18/2022
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis
10/07/2022
The recent FDA approval of a new oral treatment for patients with amyotrophic lateral sclerosis (ALS) adds another option for individuals who are diagnosed with the non-curable disease.
10/07/2022
Movement Disorders
Movement Disorders
08/28/2019
After 4 clinical trials showed the treatment decreased daily “off” time, the FDA approved this new add-on therapy for adults with Parkinson disease.
08/28/2019